1614P PSA responses and PSMA scan changes after immunotherapy for biochemically recurrent prostate cancer (BCR) without androgen deprivation therapy (ADT)Ravi A. Madan, Fatima Karzai, Sheri McMahon et al.|Annals of Oncology|2024Cited by 2
A study of prospective monitoring of patients with recurrent prostate cancer using serial PSMA imaging (18F-DCFPyL).Mohammad Atiq, Ravi A. Madan, Liza Lindenberg et al.|Journal of Clinical Oncology|2023Cited by 0
Willingness of patients with biochemically recurrent prostate cancer (BCR) with positive 18F-dcfpyl PET/CT PSMA to monitor without treatment.Monique Williams, Ravi A. Madan, Amy Hankin et al.|Journal of Clinical Oncology|2024Cited by 0
2393P Prospective monitoring of prostate specific membrane antigen (PSMA) in biochemically recurrent prostate cancer (BCR): Preliminary data from 1 Year follow-upRavi A. Madan, Peter Choyke, Melissa L. Abel et al.|Annals of Oncology|2025Cited by 0